Siemens Healthineers is joining forces with Imricor Medical Systems to develop an integrated system that combines the clinical benefits of real-time magnetic resonance imaging (MRI) scans with 3D-guided cardiac ablation.
The companies’ goal is the development of MRI-compatible devices that translate information on cardiac conduction, morphological substrates, and individual patient anatomy into better treatment outcomes, according to a press release. This approach will potentially enable electrophysiologists to treat heart arrhythmia without radiation and to use the visualisation of soft tissue information obtained through MRI.
“This partnership is planned to help us better translate patients’ individual pathophysiology into personalised treatment approaches,” explains Christoph Zindel, Senior Vice President and General Manager of Magnetic Resonance Imaging at Siemens Healthineers. “MRI guidance will not only minimise radiation exposure to patients and EP staff. This technology will enable more detailed insights into the target anatomy and tissue properties, and holds the potential to improve clinical outcomes in arrhythmia therapy. Together with Imricor, we are committed to further developing EP solutions for the benefit of the rising population of arrhythmia patients.”